title: Dalteparin-induced skin necrosis in a patient with metastatic lung adenocarcinoma.
authors.affiliation: Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. afmoore@partners.org
authors.forename: Allan
authors.initials: A
authors.lastname: Moore
authors.forename: Evan
authors.initials: E
authors.lastname: Lau
authors.forename: Clarissa
authors.initials: C
authors.lastname: Yang
authors.forename: Bonnie
authors.initials: B
authors.lastname: Mackool
authors.forename: David J
authors.initials: DJ
authors.lastname: Kuter
mesh_terms: D000230:Adenocarcinoma / Q000150:complications* / Q000556:secondary; D000925:Anticoagulants / Q000009:adverse effects*; D017985:Dalteparin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications / Q000556:secondary; D008175:Lung Neoplasms / Q000150:complications* / Q000473:pathology; D008875:Middle Aged; D009336:Necrosis; D011655:Pulmonary Embolism / Q000188:drug therapy; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology; D020246:Venous Thrombosis / Q000188:drug therapy
chemical_list: D000925:Anticoagulants; D017985:Dalteparin